Cover Image

Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Mie Waede, Lasse F. Voss, Christina Kingo, Jesper B. Moeller, Maria L. Elkjaer, Zsolt Illes
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Annals of Clinical and Translational Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets
by: Julia Feige, et al.
Published: (2024)

Phenotypic Changes in a Monocyte Cluster with High Interleukin‐1 Beta Expression during Long‐Term Anti‐ CD20 Therapy
by: Mie Waede, et al.
Published: (2025)

Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors
by: Saira Afzal, et al.
Published: (2024)

In vivo evidence for cell body loss in cortical lesions in people with multiple sclerosis
by: Eva A. Krijnen, et al.
Published: (2024)

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis
by: Pietro Iaffaldano, et al.
Published: (2024)

Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
by: Kian Jalaleddini, et al.
Published: (2024)

Rituximab in secondary progressive multiple sclerosis: a meta‐analysis
by: Pasin Intarakhao, et al.
Published: (2024)

Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID ‐19 vaccination
by: Ilya Kister, et al.
Published: (2024)

An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis
by: Ermelinda De Meo, et al.
Published: (2025)

Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis
by: Eva A. Krijnen, et al.
Published: (2024)

Improving criteria for dissemination in space in multiple sclerosis by including additional regions
by: Michael A. Foster, et al.
Published: (2024)

Chronic active lesions preferentially localize in watershed territories in multiple sclerosis
by: Ahmad A. Toubasi, et al.
Published: (2024)

Structural and functional imaging features of cognitive phenotypes in pediatric multiple sclerosis
by: Damiano Mistri, et al.
Published: (2024)

Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study
by: Tobias Moser, et al.
Published: (2024)

Ethnoracial disparities in gray matter atrophy are mediated by structural disconnectivity in multiple sclerosis
by: Ahmed Bayoumi, et al.
Published: (2025)

Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis
by: Monica Margoni, et al.
Published: (2024)

Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis
by: Evan Madill, et al.
Published: (2024)

Nicolau syndrome following glatiramer acetate for multiple sclerosis: Case and review of reports
by: Methma Udawatta, et al.
Published: (2024)

Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis
by: Jack A. Reeves, et al.
Published: (2024)

Impact of paramagnetic rim lesions on disability and race in multiple sclerosis: mediation analysis
by: Nara M. Michaelson, et al.
Published: (2024)

Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold
by: Gabriel Bsteh, et al.
Published: (2024)

Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review
by: Patricia K. Coyle, et al.
Published: (2024)

Subclinical imaging activity in multiple sclerosis patients during war‐related psychological stress
by: Omri Zveik, et al.
Published: (2024)

Brain lesion characteristics in Chinese multiple sclerosis patients: A 7‐T MRI cohort study
by: Lei Su, et al.
Published: (2024)

Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta‐analysis
by: Nabil K. El Ayoubi, et al.
Published: (2024)

Cortical lesions impact cognitive decline in multiple sclerosis via volume loss of nonlesional cortex
by: Eva A. Krijnen, et al.
Published: (2024)

Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile
by: Maria Inmaculada Dominguez‐Mozo, et al.
Published: (2025)

Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation
by: Benjamin Beland, et al.
Published: (2024)

Loneliness as neurobehavioral issue in amyotrophic lateral sclerosis
by: Monica Consonni, et al.
Published: (2024)

Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
by: Daisuke Ito, et al.
Published: (2024)

Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptoms
by: Charlotte Zejlon, et al.
Published: (2024)

Interaction between riluzole treatment and dietary glycemic index in the disease progression of amyotrophic lateral sclerosis
by: Ikjae Lee, et al.
Published: (2025)

Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data
by: Marta Karas, et al.
Published: (2024)

Cognitive Impairment in Multiple Sclerosis: The Role of Clinical and Sociodemographic Factors ‐ A Systematic Review and Meta‐Analysis
by: Katalin Lugosi, et al.
Published: (2025)

Four‐hour‐delayed 3D‐FLAIR MRIs in patients with acute unilateral peripheral vestibulopathy
by: Keun‐Tae Kim, et al.
Published: (2024)

Longitudinal Assessment of Biomarkers in ALS : Discriminative Biomarkers for Disease Progression and Survival
by: David R. Beers, et al.
Published: (2026)

Epigenome‐wide association study, meta‐analysis, and multiscore profiling of whole blood in Parkinson's disease
by: Ingeborg Haugesag Lie, et al.
Published: (2025)

Correspondence of MRI and nTMS With EDSS in Multiple Sclerosis: Longitudinal Follow‐Up Study
by: Antonia Bralić, et al.
Published: (2025)

No replicating evidence for anti‐amyloid‐β autoantibodies in cerebral amyloid angiopathy‐related inflammation
by: Emma van den Berg, et al.
Published: (2024)

CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM
by: Hui Sun, et al.
Published: (2024)